drugset / Trial / NCT00559871
Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Fipamezole is effective in the treatment of levodopa-induced dyskinesia in advanced Parkinson's disease.
Timeline
- Start
- 2007-10
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fipamezole | Small molecule | 30 mg | Other |
| Comparator | Fipamezole | Small molecule | 60 mg | Other |
| Comparator | Fipamezole | Small molecule | 90 mg | Other |